
Articles
-
1 week ago |
chemistanddruggist.co.uk | Molly Bowcott
HomePfizer scraps second attempt at weight loss pill Pfizer has announced it will “discontinue” the development of a weight loss pill amid “potential drug-induced liver injury”, less than two years after it decided “not [to] advance” a previous version. Pfizer has decided to "discontinue development" of the weight loss pill
-
1 week ago |
chemistanddruggist.co.uk | Molly Bowcott
HomeRSV jab pilot to expand by ‘up to’ 200 pharmacies The DH has revealed plans to expand the pharmacy RSV vaccine programme by “up to 200 sites in identified target areas” in 2025/26 to “reverse the downward trend” in uptake. NHSE will "expand...the community pharmacy vaccination offer by up to 200 sites" (Shutterstock)
-
1 week ago |
chemistanddruggist.co.uk | Molly Bowcott
HomePharmacist busts vet pretending dad’s tramadol was for dog A vet has been suspended for issuing a “false prescription” of tramadol for a dog she “randomly” picked that was actually intended for the treatment of her father. The vet prescribed tramadol for "a dog named Murphy", intended for her dad
-
1 week ago |
chemistanddruggist.co.uk | Molly Bowcott
HomeContract timeline at a glance: What is happening when? Following the announcement of the long-awaited pharmacy funding deal, C+D sets out a timeline of when changes are due to be implemented over the course of the next year… New contract changes are set to be implemented in the coming months... • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images
-
1 week ago |
chemistanddruggist.co.uk | Molly Bowcott
Home‘Cannabliss’ pharmacist pair sanctioned for lack of ‘adequate safeguards’ Two pharmacists have received sanctions from the GPhC for failing to “provide assurance” that cannabis based medicinal products (CBMP) were “appropriately prescribed” with “adequate” safeguards in place. The “operating model” at Cannabliss was “non-compliant and unsafe”
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →